These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35209193)

  • 1. Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
    Shao M; Jiang L; Meng Z; Xu J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
    Lippmann C; Kringel D; Ultsch A; Lötsch J
    Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
    Zong N; Wong RSN; Ngo V
    Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision drug repurposing via convergent eQTL-based molecules and pathway targeting independent disease-associated polymorphisms.
    Vitali F; Berghout J; Fan J; Li J; Li Q; Li H; Lussier YA
    Pac Symp Biocomput; 2019; 24():308-319. PubMed ID: 30864332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative bioinformatic analyses of an oncogenomic profile reveal the biology of endometrial cancer and guide drug discovery.
    Wong HS; Juan YS; Wu MS; Zhang YF; Hsu YW; Chen HH; Liu WM; Chang WC
    Oncotarget; 2016 Feb; 7(5):5909-23. PubMed ID: 26716509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeepDRA: Drug repurposing using multi-omics data integration with autoencoders.
    Mohammadzadeh-Vardin T; Ghareyazi A; Gharizadeh A; Abbasi K; Rabiee HR
    PLoS One; 2024; 19(7):e0307649. PubMed ID: 39058696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.